| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Analgesic effects of prostaglandin synthesis inhibition by diclofenac sodium
|
Kral, John G.
|
|
1985
|
15 |
2S1 |
p. 93-96
4 p.
|
article
|
| 2 |
Current concepts in the rheumatic diseases: Etiology and treatment
|
Hart, Francis Dudley
|
|
1985
|
15 |
2S1 |
p. 4-7
4 p.
|
article
|
| 3 |
Diclofenac in the treatment of ankylosing spondylitis: Review of worldwide clinical experience and report of a double-blind comparison with indomethacin
|
Khan, Muhammad Asim
|
|
1985
|
15 |
2S1 |
p. 80-84
5 p.
|
article
|
| 4 |
Diclofenac in the treatment of painful joints and traumatic tendinitis (including strains and sprains): A brief review
|
Machtey, Israel
|
|
1985
|
15 |
2S1 |
p. 87-92
6 p.
|
article
|
| 5 |
Diclofenac sodium in the treatment of rheumatoid arthritis and osteoarthritis
|
Caldwell, Jacques R.
|
|
1985
|
15 |
2S1 |
p. 73-79
7 p.
|
article
|
| 6 |
Introduction: The art and science of nonsteroidal anti-inflammatory drug selection
|
Gottlieb, Norman L.
|
|
1985
|
15 |
2S1 |
p. 1-3
3 p.
|
article
|
| 7 |
Marine sponge aggregation: A model for effects of NSAIDs on the calcium movements of cell activation
|
Weissmann, Gerald
|
|
1985
|
15 |
2S1 |
p. 42-53
12 p.
|
article
|
| 8 |
Mechanisms of cartilage degradation: Relation to choice of therapeutic agent
|
Cooke, Theodore Derek Vernon
|
|
1985
|
15 |
2S1 |
p. 16-23
8 p.
|
article
|
| 9 |
Panel discussion I
|
|
|
1985
|
15 |
2S1 |
p. 14-15
2 p.
|
article
|
| 10 |
Panel Discussion II
|
|
|
1985
|
15 |
2S1 |
p. 54-56
3 p.
|
article
|
| 11 |
Panel discussion III
|
|
|
1985
|
15 |
2S1 |
p. 85-86
2 p.
|
article
|
| 12 |
Panel Discussion IV
|
|
|
1985
|
15 |
2S1 |
p. 97-98
2 p.
|
article
|
| 13 |
Pathogenesis of osteoarthritis and use of diclofenac in the treatment of experimental models
|
Pelletier, Jean-Pierre
|
|
1985
|
15 |
2S1 |
p. 24-28
5 p.
|
article
|
| 14 |
Pharmacology of diclofenac sodium (Voltaren®)
|
Scholer, Dietrich W.
|
|
1985
|
15 |
2S1 |
p. 61-64
4 p.
|
article
|
| 15 |
Prostaglandins, thromboxanes, and leukotrienes in inflammation
|
Malmsten, Curt L.
|
|
1985
|
15 |
2S1 |
p. 29-35
7 p.
|
article
|
| 16 |
Special studies of diclofenac and safety: Gastrointestinal, renal, hepatic, and other consequences of therapy
|
Roth, Sanford H.
|
|
1985
|
15 |
2S1 |
p. 99-104
6 p.
|
article
|
| 17 |
Synovial fluid concentrations of diclofenac in patients with rheumatoid arthritis or osteoarthritis
|
Benson, Merrill D.
|
|
1985
|
15 |
2S1 |
p. 65-67
3 p.
|
article
|
| 18 |
The effects of diclofenac sodium on arachidonic acid metabolism
|
Ku, Edmond C.
|
|
1985
|
15 |
2S1 |
p. 36-41
6 p.
|
article
|
| 19 |
The history of diclofenac
|
Sallmann, Alfred R.
|
|
1985
|
15 |
2S1 |
p. 57-60
4 p.
|
article
|
| 20 |
Therapeutic significance of laboratory results in rheumatic disease
|
Wright, Verna
|
|
1985
|
15 |
2S1 |
p. 8-13
6 p.
|
article
|
| 21 |
Worldwide clinical safety experience with diclofenac
|
Willkens, Robert F.
|
|
1985
|
15 |
2S1 |
p. 105-110
6 p.
|
article
|
| 22 |
Worldwide experience with diclofenac in rheumatoid arthritis and osteoarthritis
|
Macauley, David
|
|
1985
|
15 |
2S1 |
p. 68-72
5 p.
|
article
|
Journal description